跳至主要内容
临床试验/NCT05165615
NCT05165615Unknown不适用

Comparison of the Two Different Closed-loop Hybrid Systems - AndroidAPS and Control-IQ in Patients With Type 1 Diabetes

Charles University, Czech Republic1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2020年12月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
20
试验地点
1
主要终点
Percentage of time in target ranges

研究概览

简要总结

The aim of the investigator's study is to compare two different closed loop hybrid systems - certified Control-IQ and noncertified AndroidAPS in adult patients with Type 1 Diabetes (T1D), who had been using AndroidAPS previously from their own decision, during 12 weeks of follow-up.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Type 1 diabetes diagnosed >2 years
  • ≥ 18 years old
  • written informed consent prior to starting study related activity
  • previous user of AndroidAPS at least for 3 months

排除标准

  • severe noncompliance
  • lactation, pregnancy, intending to become pregnant during study
  • use of medication with effects on carbohydrate metabolism

结局指标

主要结局

Percentage of time in target ranges

时间窗: Up to 28 weeks

3.9-10.0 mmol/L (70-180 mg/dl)

次要结局

  • Changes in glycemic variability(Up to 28 weeks)
  • Changes in glycated haemoglobin (HbA1c)(Up to 28 weeks)
  • Percentage of time in hypoglycemic ranges(Up to 28 weeks)
  • Percentage of time in hyperglycemic ranges(Up to 28 weeks)
  • Incidence of severe hypoglycaemia(Up to 28 weeks)
  • Diabetes Distress Scale (DDS)(Up to 28 weeks)
  • The 5-item World Health Organization well-being index (WHO-5 index)(Up to 28 weeks)
  • Hypoglycemia Attitudes and Behavior Scale (HABS)(Up to 28 weeks)

研究者

发起方
Charles University, Czech Republic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jan Soupal, MD

Principal Investigator

Charles University, Czech Republic

研究点 (1)

Loading locations...

相似试验